Delivery Order SPE2DB24D2101-SPE2DB25FKFFY
Award Date
11/4/24
Potential Completion Date
11/26/24
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA), a defense agency. The $80,593.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 13, 2025, with a completion date of June 4, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The contract, valued at $3,141.08, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 2, 2024. This award is not associated with any set-aside designation. Amerisourcebergen...
This federal contract award is for the delivery of PROQUAD VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,623.78, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 24, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,740.49 firm-fixed-price delivery order is for the procurement of 4,568,032,234 PROQUAD VIALS. The contract has an ultimate completion date of May 13, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a $6,683.60 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. The contract has an ultimate completion date of June 20, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, that provides a comprehensive global pharmaceutical...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,247.58, is for the delivery of PROQUAD VIALS and has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award is for the delivery of PROQUAD VIALS medical products to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office division. The contract has a ceiling value of $9,611.94 and is a Firm Fixed Price Delivery Order. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025 to provide a comprehensive range of...
This federal contract award is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, based in Conshohocken, Pennsylvania. The contract is a firm fixed price delivery order with a potential value of $3,203.98 and a completion date of March 15, 2024. This award is not associated with any set-aside designations. Amerisourcebergen Drug Corp holds an...
The Department of Defense's Defense Logistics Agency (DLA) awarded a $20,799.75 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division to provide PROQUAD VIALS. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), an alternate name for which is the Defense Logistics Agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $4,962.99, for the delivery of PROQUAD VIALS. The contract has an ultimate completion date of June 27, 2025 and was awarded on June 5, 2025. The contract is not designated as a...